Brian Jung
About Brian Jung
Brian Jung serves as the Chief Financial Officer at AiCure, where he has worked since 2021. He has held various CFO positions at companies such as Karius, Inc., Arterys, and Nanōmix, and has a strong educational background with degrees from The London School of Economics, Harvard University, and Cornell University.
Work at AiCure
Brian Jung has served as the Chief Financial Officer at AiCure since 2021. In this role, he has been instrumental in preparing the company for an initial public offering (IPO). His contributions have also included extensive experience in equity and debt facility fundraising, which has supported AiCure's financial growth. Additionally, he has played a significant role in the infrastructure scale-up of the company, enhancing operational efficiency and supporting its expansion.
Previous Experience
Before joining AiCure, Brian Jung held several key financial leadership positions. He was the Chief Financial Officer at Karius, Inc. for one year from 2017 to 2018. He then served as CFO at Arterys from 2018 to 2021, where he continued to build on his expertise. Earlier in his career, he was CFO at Nanōmix from 2014 to 2017 and at Cal eConnect from 2010 to 2012. Additionally, he worked as the Chief Business Development Officer at Alameda Hospital from 2012 to 2014.
Education and Expertise
Brian Jung has a strong educational background with degrees from prestigious institutions. He studied at The London School of Economics and Political Science (LSE), where he achieved a Diploma in Business Studies (DBS). He also holds a Master of Public Health (MPH) from Harvard University and a Master of Business Administration (MBA) from Cornell University. His education complements his extensive experience in financial management, mergers and acquisitions (M&A) analysis, and strategic financial planning.
Financial Leadership Roles
Brian Jung has held various leadership roles in finance throughout his career. He served as Executive Director of KPIT Finance at Kaiser Permanente IT from 2005 to 2007. His roles have consistently focused on financial strategy and management, contributing to the growth and operational success of the organizations he has been part of. His expertise in fundraising and M&A analysis has been a significant asset in his positions.